NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Trial of Academic Detailing to Promote Prescribing of Biosimilars

Active Not RecruitingNA

Sponsor: Brigham and Women's Hospital

Conditions: Autoimmune Diseases, Rheumatoid Arthritis (RA), Inflammatory Bowel Disease (IBD), Psoriasis (PsO)

Interventions: Offered an academic detailing session, Standard-of-care outreach from the insurance plan

Countries: United States

The goal of this trial is to learn if an interactive evidence-based educational outreach visits to clinicians who prescribe biologics change prescribing of biosimilar medications. The main questions it aims to answer are: 1. Do educational outreach visits lead to a higher number of prescriptions for biosimilar versions of adalimumab? 2. Do in-person or virtual visits work better? Researchers will compare clinicians offered the educational outreach visit to those who are not offered the visit to see if there is a difference in prescribing of biosimilar versions of adalimumab instead of the original brand-name version. Participants will be offered the chance to meet with a trained clinician who will provide educational information tailored to their knowledge and attitudes on the topic. They will also be provided an educational brochure and patient educational materials.

Eligibility overview

Sex: ALL

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Wrote 7 or more adalimumab prescriptions that were filled by patients enrolled in research-eligible Humana Medicare Part D plans in the calendar year 2025

Exclusion Criteria:

* Retired
* Not able to identify active clinical practice in the US (50 states plus Washington DC)

Locations (2)

Louisville, Kentucky, United States
Boston, Massachusetts, United States